TCM
IMMU

TimesSquare Capital Management’s Immunomedics Inc IMMU Stock Holding History

TimesSquare Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,367,600
Closed -$116M – 255
2020
Q3 		$116M Sell
1,367,600
-443,400
-24% -$22.4M 1.09% 11
2020
Q2 		$64.2M Buy
+1,811,000
New +$52.9M 0.61% 54
2019
Q4 		– Sell
-892,660
Closed -$11.8M – 239
2019
Q3 		$11.8M Sell
892,660
-1,346,940
-60% -$19.8M 0.1% 193
2019
Q2 		$31.1M Sell
2,239,600
-70,600
-3% -$1.06M 0.24% 146
2019
Q1 		$44.4M Buy
+2,310,200
New +$37.2M 0.34% 125

TimesSquare Capital Management's IMMU Position: Q4 2020 in Review

TimesSquare Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,367,600 shares — an estimated $116M sold.

TimesSquare Capital Management first reported a position in IMMU in Q1 2019 and held it in 5 quarters. The position peaked at $116M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • TimesSquare Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • TimesSquare Capital Management sold 1,367,600 Immunomedics Inc shares in Q4 2020, an estimated $116M.
  • TimesSquare Capital Management first reported a position in Immunomedics Inc in Q1 2019 and held it in 5 quarters.
  • TimesSquare Capital Management's Immunomedics Inc position peaked at $116M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on TimesSquare Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.